메뉴 건너뛰기




Volumn 24, Issue 9, 2007, Pages 1159-1160

Anti TNF alpha therapy - A risk factor for legionella infection [2];Traitement par anti-TNF alpha: Un risque accru de légionellose

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; ERYTHROMYCIN; ETANERCEPT; HEMOGLOBIN; LEVOFLOXACIN; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

EID: 37349011274     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(07)74271-7     Document Type: Letter
Times cited : (5)

References (7)
  • 1
    • 13844318882 scopus 로고    scopus 로고
    • Complications respiratoires des nouveaux traitements de la maladie rhumatoïde
    • Liote H : Complications respiratoires des nouveaux traitements de la maladie rhumatoïde. Rev Mal Respir 2004 ; 21 : 1107-15.
    • (2004) Rev Mal Respir , vol.21 , pp. 1107-1115
    • Liote, H.1
  • 2
    • 17644374819 scopus 로고    scopus 로고
    • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
    • Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, Olsson H, Jacobsson LT : Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005 ; 64 : 699-703.
    • (2005) Ann Rheum Dis , vol.64 , pp. 699-703
    • Geborek, P.1    Bladstrom, A.2    Turesson, C.3    Gulfe, A.4    Petersson, I.F.5    Saxne, T.6    Olsson, H.7    Jacobsson, L.T.8
  • 3
    • 2642553833 scopus 로고    scopus 로고
    • A case of legionellosis during treatment with a TNFalpha antagonist
    • Wondergem MJ, Voskuyl AE, Van Agtmael MA : A case of legionellosis during treatment with a TNFalpha antagonist. Scand J Infect Dis 2004 ; 36 : 310-1.
    • (2004) Scand J Infect Dis , vol.36 , pp. 310-311
    • Wondergem, M.J.1    Voskuyl, A.E.2    Van Agtmael, M.A.3
  • 4
    • 17744369686 scopus 로고    scopus 로고
    • Pneumonitis caused by legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab)
    • Li Gobbi F, Benucci M, Del Rosso A : Pneumonitis caused by legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab). J Clin Rheumatol 2005 ; 11 : 119-20.
    • (2005) J Clin Rheumatol , vol.11 , pp. 119-120
    • Li Gobbi, F.1    Benucci, M.2    Del Rosso, A.3
  • 6
    • 17444408886 scopus 로고    scopus 로고
    • Fatal fulminant legionnaire's disease in a patient with severe erythrodermic psoriasis treated with infliximab after long term steroid therapy
    • Eisendle K, Fritsch P : Fatal fulminant legionnaire's disease in a patient with severe erythrodermic psoriasis treated with infliximab after long term steroid therapy. Br J Dermatol 2005 ; 152 : 585-6.
    • (2005) Br J Dermatol , vol.152 , pp. 585-586
    • Eisendle, K.1    Fritsch, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.